Brazil
· Delayed Price · Currency is BRL Biomm Statistics
Total Valuation
Biomm has a market cap or net worth of BRL 1.18 billion. The enterprise value is 1.14 billion.
| Market Cap | 1.18B |
| Enterprise Value | 1.14B |
Important Dates
The last earnings date was Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomm has 126.84 million shares outstanding. The number of shares has increased by 43.84% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 126.84M |
| Shares Change (YoY) | +43.84% |
| Shares Change (QoQ) | -1.62% |
| Owned by Insiders (%) | 12.87% |
| Owned by Institutions (%) | 38.25% |
| Float | 53.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.66 |
| PB Ratio | 4.04 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.67 |
| EV / Sales | 9.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.43 |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.44.
| Current Ratio | 3.36 |
| Quick Ratio | 2.53 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.26 |
| Interest Coverage | -3.44 |
Financial Efficiency
Return on equity (ROE) is -37.53% and return on invested capital (ROIC) is -14.13%.
| Return on Equity (ROE) | -37.53% |
| Return on Assets (ROA) | -11.45% |
| Return on Capital (ROIC) | -14.13% |
| Revenue Per Employee | 945,454 |
| Profits Per Employee | -559,238 |
| Employee Count | 130 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 2.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.26% in the last 52 weeks. The beta is 0.86, so Biomm's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +55.26% |
| 50-Day Moving Average | 9.50 |
| 200-Day Moving Average | 11.26 |
| Relative Strength Index (RSI) | 48.39 |
| Average Volume (20 Days) | 69,610 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biomm had revenue of BRL 122.91 million and -72.70 million in losses. Loss per share was -0.64.
| Revenue | 122.91M |
| Gross Profit | 24.09M |
| Operating Income | -75.68M |
| Pretax Income | -72.63M |
| Net Income | -72.70M |
| EBITDA | -63.00M |
| EBIT | -75.68M |
| Loss Per Share | -0.64 |
Balance Sheet
The company has 166.05 million in cash and 126.00 million in debt, giving a net cash position of 40.05 million or 0.32 per share.
| Cash & Cash Equivalents | 166.05M |
| Total Debt | 126.00M |
| Net Cash | 40.05M |
| Net Cash Per Share | 0.32 |
| Equity (Book Value) | 288.37M |
| Book Value Per Share | 2.30 |
| Working Capital | 188.65M |
Cash Flow
In the last 12 months, operating cash flow was -98.63 million and capital expenditures -1.08 million, giving a free cash flow of -99.71 million.
| Operating Cash Flow | -98.63M |
| Capital Expenditures | -1.08M |
| Free Cash Flow | -99.71M |
| FCF Per Share | -0.79 |
Margins
Gross margin is 19.60%, with operating and profit margins of -61.57% and -59.15%.
| Gross Margin | 19.60% |
| Operating Margin | -61.57% |
| Pretax Margin | -59.09% |
| Profit Margin | -59.15% |
| EBITDA Margin | -51.26% |
| EBIT Margin | -61.57% |
| FCF Margin | -81.12% |
Dividends & Yields
Biomm does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.84% |
| Shareholder Yield | -43.84% |
| Earnings Yield | -6.83% |
| FCF Yield | -8.45% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |